Validation of diffusivity analysis along the perivascular space (ALPS) index as a biomarker for vascular cognitive impairment and dementia

Motivation: To test the validity of the ALPS index as a biomarker for VCIDGoal(s): To test our hypothesis that ALPS index is an independent biomarker for the cognitive decline in cSVD. Approach: Participants from MarkVCID consortium underwent baseline and follow-up MRI examinations and clinical evaluations of cognitive functionResults: We found the baseline ALPS index was correlated with the existing biomarkers of cSVD and VCID, and was independently associated with the baseline cognitive performanceImpact: Our study provides the clinical validation of the ALPS index as a sensitive and independent biomarker for the cognitive function of cSVD related VCID.

Authors

Publication Details

Journal
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Published
2024-11-26
DOI
https://doi.org/10.58530/2024/2636
Primary Topic
Cerebrospinal fluid and hydrocephalus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of diffusivity analysis along the perivascular space (ALPS) index as a biomarker for vascular cognitive impairment and dementia

Charles DeCarli, Brian T. Gold, Steven Cen, Mohamad Habes et al.
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Cerebrospinal fluid and hydrocephalus
article

Validation of diffusivity analysis along the perivascular space (ALPS) index as a biomarker for vascular cognitive impairment and dementia

Charles DeCarli, Brian T. Gold, Steven Cen, Mohamad Habes, Bruce Fischl, Hanzhang Lu, Lara Stables, Arvind Caprihan, Xingfeng Shao, Giuseppe Barisano, Kay Jann, Konstantinos Arfanakis, Pauline Maillard, Kristin Schwab, Steven Mark Greenberg, Danny J.J. Wang, Herpreet Singh, John M. Ringman, André van der Kouwe, Karl G. Helmer, Xiaodan Liu, Clandia L. Satizabal
article en

Abstract

Motivation: To test the validity of the ALPS index as a biomarker for VCIDGoal(s): To test our hypothesis that ALPS index is an independent biomarker for the cognitive decline in cSVD. Approach: Participants from MarkVCID consortium underwent baseline and follow-up MRI examinations and clinical evaluations of cognitive functionResults: We found the baseline ALPS index was correlated with the existing biomarkers of cSVD and VCID, and was independently associated with the baseline cognitive performanceImpact: Our study provides the clinical validation of the ALPS index as a sensitive and independent biomarker for the cognitive function of cSVD related VCID.

Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition
Openalex Percentile: Top 78%
Cerebrospinal fluid and hydrocephalus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.